Inspire Medical SystemsINSP
INSP
About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Employees: 1,246
0
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
19% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 113
18% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 51
2.91% more ownership
Funds ownership: 111.42% [Q4 2024] → 114.33% (+2.91%) [Q1 2025]
2% more funds holding
Funds holding: 352 [Q4 2024] → 359 (+7) [Q1 2025]
5% more call options, than puts
Call options by funds: $36.7M | Put options by funds: $34.9M
12% less capital invested
Capital invested by funds: $6.2B [Q4 2024] → $5.45B (-$749M) [Q1 2025]
25% less funds holding in top 10
Funds holding in top 10: 8 [Q4 2024] → 6 (-2) [Q1 2025]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$174
34%
upside
Avg. target
$197
52%
upside
High target
$236
82%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Keybanc Brett Fishbin | 52%upside $197 | Overweight Maintained | 22 Jul 2025 |
Morgan Stanley Kallum Titchmarsh | 40%upside $182 | Overweight Maintained | 15 Jul 2025 |
JP Morgan Robbie Marcus | 50%upside $195 | Overweight Maintained | 6 May 2025 |
Wells Fargo Larry Biegelsen | 34%upside $174 | Equal-Weight Maintained | 6 May 2025 |
Baird Mike Polark | 82%upside $236 | Outperform Maintained | 6 May 2025 |
Financial journalist opinion
Based on 4 articles about INSP published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Positive
Zacks Investment Research
1 week ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Positive
Zacks Investment Research
2 weeks ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Neutral
GlobeNewsWire
3 weeks ago
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m.
Positive
The Motley Fool
1 month ago
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.
Neutral
Zacks Investment Research
1 month ago
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Positive
Seeking Alpha
1 month ago
Inspire Medical Systems: Investors Should Sleep Better From Here Onwards
Inspire Medical's growth remains strong, with 2025 seen as a transition year due to the Inspire V launch, causing near-term margin volatility. Valuations look more attractive: shares trade at just 4x sales, a significant discount from previous highs, while the business is profitable and growing. Concerns about GLP-1 drugs impacting demand are likely overblown, as these patients were not ideal candidates for Inspire's therapy anyway.
Neutral
GlobeNewsWire
1 month ago
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025. Inspire is scheduled to present at 11:20 a.m.
Neutral
GlobeNewsWire
2 months ago
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2025 MedTech Innovation Spotlight on Friday, June 13, 2025.
Neutral
GlobeNewsWire
2 months ago
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine.
Charts implemented using Lightweight Charts™